Remember meForgot password?
    Log in with Twitter
Press Release

FDA Releases Warning And Invokana Lawsuit Plaintiffs Claim Drug Causes Dangerous Side Effects reports on possible Invokana side effects and a U.S. Food and Drug Administration (FDA) public safety announcement dated December 4, 2015, that discussed its mandate that Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson, revise its warning label to better reflect the nature of potential side effects of taking Invokana and other sodium glucose cotransporter 2 (SGLT2) inhibitor drugs. The mandate specifically addressed the potential for kidney damage and failure. Additionally, kidney damage has also been the subject of recent Invokana lawsuits against Janssen.

Invokana was approved by the FDA in 2013 as a treatment for type-2 diabetes. Its primary purpose is to maintain blood sugar (glucose) levels and does so by impeding the kidneys from absorbing excess sugar. Instead, it uses the kidneys to dispose of this excess sugar via urination, thus causing an increased amount of stress on the kidneys. The FDA in its public safety communication has stated that it received numerous reports within the first year Invokana was on the market, dealing with renal system impairment and kidney failure by diabetes patients taking the drug.

Of the reports received by the FDA, 19 cited claims by patients that they developed life-threatening ailments that began as urinary tract infections (UTIs) but subsequently turned into blood or kidney infections. All of the patients filing these reports alleged to have required hospitalization and kidney failure treatment with dialysis. Once the kidneys are damaged it is irreversible and, many times, requires enduring dialysis while patients await a kidney transplant that is a long, arduous and very stressful process.

Many believe that the risk to the kidneys can be made much worse in patients who have preexisting kidney damage, as diabetes is a condition that has been documented to be very hard on the organs. Additionally, there have been reports of other life-threatening medical conditions possibly linked to the use of Invokana such as diabetic ketoacidosis, heart attack, and stroke.

For more information about the Invokana lawsuits, or this press release, please contact on 888-997-3792.



Banville Law
165 West End Ave #1h, New York, NY 10023

Latest News
Top News